ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -37.5% | 7,986 | 0.0% | 0.00% | – |
| Q2 2023 | $40 | -2.4% | 7,986 | -3.2% | 0.00% | – |
| Q1 2023 | $41 | -35.9% | 8,246 | -19.1% | 0.00% | -100.0% |
| Q4 2022 | $64 | -99.9% | 10,192 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $110,000 | -4.3% | 10,192 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $115,000 | +35.3% | 10,093 | +7.9% | 0.00% | 0.0% |
| Q1 2022 | $85,000 | -71.7% | 9,350 | -53.6% | 0.00% | 0.0% |
| Q4 2021 | $300,000 | +14.5% | 20,172 | +98.1% | 0.00% | -50.0% |
| Q3 2021 | $262,000 | -7.7% | 10,184 | -6.4% | 0.00% | 0.0% |
| Q2 2021 | $284,000 | +4.8% | 10,875 | +41.7% | 0.00% | -80.0% |
| Q1 2021 | $271,000 | +27.2% | 7,676 | -8.9% | 0.01% | +25.0% |
| Q4 2020 | $213,000 | -32.6% | 8,426 | +0.5% | 0.01% | -42.9% |
| Q3 2020 | $316,000 | -4.8% | 8,380 | +8.0% | 0.01% | -6.7% |
| Q2 2020 | $332,000 | – | 7,762 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |